Home / India / Human trials of indigenous COVID-19 vaccine candidates move to Phase 2: ICMR
Human trials of indigenous COVID-19 vaccine candidates move to Phase 2: ICMR

Human trials of indigenous COVID-19 vaccine candidates move to Phase 2: ICMR

NEW DELHI: The human clinical trials of two COVID-19 vaccine candidates developed indigenously by Bharat Biotech in collaboration with ICMR and Zydus Cadila Ltd have moved to Phase 2, ICMR Director-General Dr Balram Bhargava said.

“Recombinant Oxford vaccine being manufactured by Serum Institute was given approval for Phase 2 and 3 trials which would start within a week,” Bhargava added.

 COVAXIN, India’s first indigenous coronavirus vaccine developed by Bharat Biotech in collaboration with ICMR, and Zydus Cadila’s  ZyCoV-D, a DNA vaccine against the SARS-CoV-2, have shown satisfactory results in preclinical studies.

Giving an update related to the COVID-19 vaccine, the ICMR top boss said that there is no specific drug and vaccine available yet for the disease caused by coronavirus.

Get Breaking news and Latest News from India and around the world on GlobalPunjabTV.net. Follow us on Facebook for more updates.

Check Also

SAD appealed to all political parties to join the ‘sangharsh’ against the three agri bills:Prof Prem Singh Chandumajra

SAD appealed to all political parties to join the ‘sangharsh’ against the thre …

CHANDIGARH, SEPTEMBER 19: The Shiromani Akali Dal (SAD) today appealed to all political parties to …

Leave a Reply

Your email address will not be published. Required fields are marked *